Showing results (171-180 of 244) with videos related to

Sort By:
Pageof 25
Organic & Biomolecular Chemistry|December 25, 2014
Halide inhibition of the copper-catalysed azide-alkyne cycloadditionRebekah M Moorman, Matthew B Collier, Bram H Frohock, et al.
Biotechniques|April 1, 1995
Alternative to polyacrylamide gels improves the electrophoretic mobility shift assayP G Vanek, S J Fabian, C L Fisher, et al.
The Journal of Bone and Joint Surgery. American Volume|December 3, 2005
Osteolysis after total knee arthroplasty: influence of tibial baseplate surface finish and sterilization of polyethylene insert. Findings at five to ten years postoperativelyMatthew B Collier, C Anderson Engh, James P Mcauley, et al.
Foot & Ankle Specialist|September 11, 2016
Arthroscopic Evaluation of Syndesmotic Instability and MalreductionDouglas E Lucas, B Collier Watson, G Alex Simpson, et al.
Experimental & Molecular Medicine|March 14, 2026
Regulation of PKM2 expression and function by GLIS3 during metabolic reprogramming in polycystic kidneysJustin B Collier, Hong Soon Kang, Sara A Grimm, et al.
Synapse (New York, N.Y.)|January 1, 1988
Influx of a choline analog to dog brain measured by positron emission tomographyC Redies, M Diksic, B Collier, et al.
Revista Espanola De Anestesiologia Y Reanimacion|August 14, 2013
Electron microscopy of human peripheral nerves of clinical relevance to the practice of nerve blocks. A structural and ultrastructural review based on original experimental and laboratory dataM A Reina, R Arriazu, C B Collier, et al.
American Journal of Physiology. Renal Physiology|May 31, 2018
5-HT1F receptor regulates mitochondrial homeostasis and its loss potentiates acute kidney injury and impairs renal recoveryWhitney S Gibbs, Justin B Collier, Morgan Morris, et al.
Journal of Immunological Methods|April 7, 2018
Automated generation of immature dendritic cells in a single-use systemAndrew Kozbial, Lekhana Bhandary, Bradley B Collier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecanS Sharma, N Kemeny, D P Kelsen, et al.
Pageof 25